Company: SINT
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021930
Chunk: 7

Company: Sintx Technologies, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 8
Chunk 7
---
 (“Holdings”), pursuant to which the Company agreed to purchase substantially all the assets and assume
certain liabilities of Sinaptic Surgical. As consideration for the purchase of the assets under the Asset Purchase Agreement, the Company
agreed to issue to Sinaptic Surgical warrants to purchase 325,000 shares of the Company’s common stock (the “Warrants”).
The Warrants expire five years from the date of issue and have an exercise price of $6.30 per share. The Warrants will become exercisable
upon the achievement of certain milestones prior to the expiration of the Warrants. In connection with the Asset Purchase Agreement,
Sinaptic Surgical purchased 216,450 shares of the Company’s common stock at a purchase price of $3.465 per share in a private placement.

The
fair value for the acquired intangible asset was estimated utilizing the income approach, which involves the use of significant estimates
and assumptions including projected revenue growth rates, projected earnings, and discount rates.

The
following table summarizes the consideration transferred, the estimated fair value of the assets acquired, and liabilities assumed, at
the acquisition date (in thousands):

 Schedule
of Recognized Identified Assets Acquired and Liabilities Assumed

    Amounts recognized as of the acquisition date 
  
    Fair value of consideration transferred 

    Common stock private placement 
    $682 
  
    Warrants (included in derivative liabilities) 
     495 
  
    Total consideration transferred 
    $1,177 

    Recognized amounts of identifiable assets acquired and liabilities assumed 

    Cash 
    $750 
  
    Intangibles 
     145 
  
    Total assets acquired 
     895 

    Accounts payable and other accrued expenses 
     (20)
  
    Total identifiable net assets 
    $875 
  
    Goodwill 
    $302 

The
Company recognized goodwill of $302,000, which reflects the future benefits of certain synergies, and regulatory and commercialization strategies.
Acquired intangible assets are being amortized over the estimated useful life of five years on a straight-line basis.

    9

4.
Basic and Diluted Net Income (Loss) per Common Share

Basic
net income (loss) per share is calculated by dividing the net income (loss) by the weighted-average number of common shares outstanding
for the period, without consideration for common stock equivalents. Diluted net loss per share is calculated by dividing the net loss
by the weighted-average number of common share equivalents outstanding